Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 4/20 | 0.43 |
| ▸ | PDE4A | P27815 | 3/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1379795 | 0.90 | PDE4A (0.54) | KDM4EMAPTGAAPDE4APDE4B | |
| SCHEMBL356412 | 0.90 | KDM4E (0.59) | KDM4EMAPTGAAPDE4APDE4B | |
| SCHEMBL16953993 | 0.85 | SHMT2 (0.39) | KDM4EMAPTGAAPOLBPDE4A | |
| SCHEMBL16957605 | 0.83 | S1PR1 (0.39) | KDM4EMAPTGAAPOLBPDE4A | |
| SCHEMBL3032528 | 0.83 | PDE4A (0.36) | KDM4EMAPTGAAPOLBPDE4A | |
| SCHEMBL16961146 | 0.83 | S1PR1 (0.39) | KDM4EMAPTGAAPOLBTSHR | |
| SCHEMBL16956683 | 0.83 | RAB9A (0.43) | KDM4EMAPTGAAPDE4APDE4B | |
| SCHEMBL6583776 | 0.83 | MAPT (0.47) | KDM4EMAPTGAAPOLBPDE4A | |
| SCHEMBL16962672 | 0.83 | ALDH1A1 (0.38) | KDM4EMAPTGAAPOLBTSHR | |
| SCHEMBL16959303 | 0.83 | ESR1 (0.46) | KDM4EMAPTGAAPOLBPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060189614-A1 | Substituted diamino-1,3,5-triazine derivatives | JANSSEN PAUL A | 2006-08-24 | — | — | US | claimed |
| US-20060049177-A1 | Induction heating cooker | LG ELECTRONICS INC. | 2006-03-09 | — | — | US | claimed |
| EP-1214300-B1 | RATE-CONTROLLED PARTICLES | ABBOTT GMBH & CO KG (DE) | 2003-09-03 | — | — | EP | claimed |
| EP-1189891-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2002-03-27 | — | — | EP | claimed |
| US-6362342-B1 | BIOSYNTHESIS; DRUG LIBRARIES | LION BIOSCIENCE AG (DE) | 2002-03-26 | — | — | US | claimed |
| WO-2001000594-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-01-04 | — | — | WO | claimed |
| EP-0834507-A1 | Substituted diamino-1,3,5-triazine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-04-08 | — | — | EP | claimed |
| US-5468865-A | EFFICIENCY | CELGENE CORPORATION (US) | 1995-11-21 | — | — | US | claimed |
| WO-1995029903-A1 | STEREOPREFERENTIAL SYNTHESIS OF 3-(1-PHENYLPROP-2-YL)-5-PHENYLOXAZOLIDINONES | CELGENE CORPORATION (US) | 1995-11-09 | — | — | WO | claimed |
| US-9028876-B2 | Rate-controlled particles | JANSSEN R&D IRELAND (IE) | 2015-05-12 | — | — | US | disclosed |
| US-8883842-B2 | Use of HDAC inhibitors for the treatment of myeloma | NOVARTIS AG (CH) | 2014-11-11 | — | — | US | disclosed |
| EP-1957073-B1 | MEDICINAL DRUG | OTSUKA PHARMA CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| US-8551999-B2 | Heterocyclic compound and pharmaceutical composition thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| CN-103224488-A | Heterocyclic compound or salt thereof | OTSUKA PHARMA CO LTD | 2013-07-31 | — | — | CN | disclosed |
| US-4455430-A | ANTITUMOR AGENTS, MICROCIDES | THE UPJOHN COMPANY (US) | 1984-06-19 | — | — | US | disclosed |
| US-RE31578-E | ANTITUMOR AGENTS, BACTERICIDES | THE UPJOHN COMPANY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4429119-A | PLANT GROWTH REGULATORS | CHEVRON RESEARCH COMPANY (US) | 1984-01-31 | — | — | US | disclosed |
| US-4298744-A | CHLORINATION OF ISOMERIC ANALOG | THE UPJOHN COMPANY (US) | 1981-11-03 | — | — | US | disclosed |
| US-4275214-A | ANALOGS OF TRICHOLOMIC ACID USEFUL AS INTERMEDIATES IN THE PREPARATION OF AT-125 | THE UPJOHN COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4256898-A | INTERMEDIATES FOR MAKING (ALPHAS, 5S)-ALPHA-AMINO-3-CHLORO-2-ISOXAZOLINE-5-ACETIC ACID (AT-125) | THE UPJOHN COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060189614-A1 | Substituted diamino-1,3,5-triazine derivatives | C5, ADORA1, C1S | KDM4E 2713/4885MAPT 3917/4885GAA 3531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.